Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2207533
Max Phase: Preclinical
Molecular Formula: C56H89NO15
Molecular Weight: 1016.32
Molecule Type: Small molecule
Associated Items:
ID: ALA2207533
Max Phase: Preclinical
Molecular Formula: C56H89NO15
Molecular Weight: 1016.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)Nc2ccc3c(c2)OCCOCCOCCOCCO3)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C
Standard InChI: InChI=1S/C56H89NO15/c1-11-41(52(61)57-40-15-17-44-45(33-40)67-31-29-65-27-25-63-24-26-64-28-30-66-44)43-16-14-34(4)50(69-43)38(8)48(59)37(7)49(60)42(12-2)51-35(5)32-36(6)55(70-51)21-18-46(58)56(72-55)23-22-53(10,71-56)47-19-20-54(62,13-3)39(9)68-47/h15,17-18,21,33-39,41-43,46-48,50-51,58-59,62H,11-14,16,19-20,22-32H2,1-10H3,(H,57,61)/t34-,35-,36+,37-,38-,39-,41+,42-,43+,46+,47+,48+,50+,51-,53-,54+,55-,56-/m0/s1
Standard InChI Key: CURYHGMNQOCPJZ-UNMBMHTPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1016.32 | Molecular Weight (Monoisotopic): 1015.6232 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Huczyński A, Janczak J, Antoszczak M, Wietrzyk J, Maj E, Brzezinski B.. (2012) Antiproliferative activity of salinomycin and its derivatives., 22 (23): [PMID:23079523] [10.1016/j.bmcl.2012.09.068] |
Source(1):